Literature DB >> 21925381

Induction of antagonistic soluble decoy receptor tyrosine kinases by intronic polyA activation.

Sandra Vorlová1, Gina Rocco, Clare V Lefave, Francine M Jodelka, Ken Hess, Michelle L Hastings, Erik Henke, Luca Cartegni.   

Abstract

Alternative intronic polyadenylation (IPA) can generate truncated protein isoforms with significantly altered functions. Here, we describe 31 dominant-negative, secreted variant isoforms of receptor tyrosine kinases (RTKs) that are produced by activation of intronic poly(A) sites. We show that blocking U1-snRNP can activate IPA, indicating a larger role for U1-snRNP in RNA surveillance. Moreover, we report the development of an antisense-based method to effectively and specifically activate expression of individual soluble decoy RTKs (sdRTKs) to alter signaling, with potential therapeutic implications. In particular, a quantitative switch from signal transducing full-length vascular endothelial growth factor receptor-2 (VEGFR2/KDR) to a dominant-negative sKDR results in a strong antiangiogenic effect both on directly targeted cells and on naive cells exposed to conditioned media, suggesting a role for this approach in interfering with angiogenic paracrine and autocrine loops.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21925381      PMCID: PMC3781938          DOI: 10.1016/j.molcel.2011.08.009

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  36 in total

Review 1.  Mechanistic links between nonsense-mediated mRNA decay and pre-mRNA splicing in mammalian cells.

Authors:  Fabrice Lejeune; Lynne E Maquat
Journal:  Curr Opin Cell Biol       Date:  2005-06       Impact factor: 8.382

2.  Widespread mRNA polyadenylation events in introns indicate dynamic interplay between polyadenylation and splicing.

Authors:  Bin Tian; Zhenhua Pan; Ju Youn Lee
Journal:  Genome Res       Date:  2007-01-08       Impact factor: 9.043

Review 3.  A possible placental factor for preeclampsia: sFlt-1.

Authors:  Naoko Kita; Junji Mitsushita
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

Review 4.  Soluble receptors in human disease.

Authors:  M L Heaney; D W Golde
Journal:  J Leukoc Biol       Date:  1998-08       Impact factor: 4.962

5.  U1 snRNP inhibits pre-mRNA polyadenylation through a direct interaction between U1 70K and poly(A) polymerase.

Authors:  S I Gunderson; M Polycarpou-Schwarz; I W Mattaj
Journal:  Mol Cell       Date:  1998-01       Impact factor: 17.970

6.  Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity.

Authors:  Y He; S K Smith; K A Day; D E Clark; D R Licence; D S Charnock-Jones
Journal:  Mol Endocrinol       Date:  1999-04

7.  A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells.

Authors:  G K Scott; R Robles; J W Park; P A Montgomery; J Daniel; W E Holmes; J Lee; G A Keller; W L Li; B M Fendly
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

8.  Inhibition of solid tumor growth by gene transfer of VEGF receptor-1 mutants.

Authors:  Regina Heidenreich; Marcia Machein; Anke Nicolaus; Andreas Hilbig; Carola Wild; Matthias Clauss; Karl H Plate; Georg Breier
Journal:  Int J Cancer       Date:  2004-09-01       Impact factor: 7.396

9.  Peptide-conjugated antisense oligonucleotides for targeted inhibition of a transcriptional regulator in vivo.

Authors:  Erik Henke; Jonathan Perk; Jelena Vider; Paola de Candia; Yvette Chin; David B Solit; Vladimir Ponomarev; Luca Cartegni; Katia Manova; Neal Rosen; Robert Benezra
Journal:  Nat Biotechnol       Date:  2008-01-06       Impact factor: 54.908

10.  A large-scale analysis of mRNA polyadenylation of human and mouse genes.

Authors:  Bin Tian; Jun Hu; Haibo Zhang; Carol S Lutz
Journal:  Nucleic Acids Res       Date:  2005-01-12       Impact factor: 16.971

View more
  71 in total

1.  Widespread recognition of 5' splice sites by noncanonical base-pairing to U1 snRNA involving bulged nucleotides.

Authors:  Xavier Roca; Martin Akerman; Hans Gaus; Andrés Berdeja; C Frank Bennett; Adrian R Krainer
Journal:  Genes Dev       Date:  2012-05-15       Impact factor: 11.361

Review 2.  Alternative cleavage and polyadenylation: extent, regulation and function.

Authors:  Ran Elkon; Alejandro P Ugalde; Reuven Agami
Journal:  Nat Rev Genet       Date:  2013-07       Impact factor: 53.242

Review 3.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

Review 4.  The role of RNA alternative splicing in regulating cancer metabolism.

Authors:  Itamar Kozlovski; Zahava Siegfried; Adi Amar-Schwartz; Rotem Karni
Journal:  Hum Genet       Date:  2017-04-20       Impact factor: 4.132

Review 5.  Interorgan Communication Pathways in Physiology: Focus on Drosophila.

Authors:  Ilia A Droujinine; Norbert Perrimon
Journal:  Annu Rev Genet       Date:  2016-10-10       Impact factor: 16.830

Review 6.  Alternative polyadenylation: new insights from global analyses.

Authors:  Yongsheng Shi
Journal:  RNA       Date:  2012-10-24       Impact factor: 4.942

7.  Upregulation of functional Kv11.1 isoform expression by inhibition of intronic polyadenylation with antisense morpholino oligonucleotides.

Authors:  Qiuming Gong; Matthew R Stump; Zhengfeng Zhou
Journal:  J Mol Cell Cardiol       Date:  2014-08-14       Impact factor: 5.000

8.  Antisense Modulation of RNA Processing as a Therapeutic Approach in Cancer Therapy.

Authors:  Lee Spraggon; Luca Cartegni
Journal:  Drug Discov Today Ther Strateg       Date:  2013

9.  U1 snRNP-mediated poly(A) site suppression: beneficial and deleterious for mRNA fate.

Authors:  Jörg Langemeier; Maximilian Radtke; Jens Bohne
Journal:  RNA Biol       Date:  2013-01-16       Impact factor: 4.652

10.  Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.

Authors:  Irina Evsyukova; Shelton S Bradrick; Simon G Gregory; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2012-11-14       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.